Apellis Recommends Practitioners Immediately Discontinue Use Of Any Injection Kits That Contain 19-Gauge Filter Needle And Use Injection Kits With 18-Gauge Filter Needle
Portfolio Pulse from Benzinga Newsdesk
Apellis Pharmaceuticals has recommended that practitioners immediately discontinue the use of any injection kits that contain a 19-gauge filter needle and instead use injection kits with an 18-gauge filter needle.
August 22, 2023 | 8:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Apellis Pharmaceuticals' recommendation to discontinue the use of 19-gauge filter needle injection kits could potentially impact the company's reputation and sales.
The recommendation to discontinue a product can be seen as an admission of a problem or defect, which could negatively impact the company's reputation and sales. However, the switch to a different product (18-gauge filter needle) could mitigate some of this impact.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100